Status:

COMPLETED

A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

Lead Sponsor:

Human Genome Sciences Inc.

Conditions:

Chronic Hepatitis C

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

A Study of Albuferon with Ribavirin in Interferon Alfa Naive Subjects with Chronic Hepatitis C Genotype 2 or 3.

Detailed Description

A Randomized, Multi-Center, Open-Label Study To Evaluate The Efficacy And Safety Of Albuferon (HGS 1008, Recombinant Human Albumin-Interferon Alfa Fusion Protein) In Combination With Ribavirin In Inte...

Eligibility Criteria

Inclusion

  • Have a clinical diagnosis of chronic hepatitis C on the basis of detectable serum HCV RNA during the screening period and at least a 6-month history of exposure to risk factors for HCV.
  • Have never received treatment with an interferon alfa product or an interferon alfa combination product.
  • Have HCV genotype 2 or 3.
  • Have compensated liver disease with the following minimum criteria: white blood cell count (WBC) \>3,000/mm3, absolute neutrophil count (ANC) \> 1,800/mm3, platelets \>100,000/mm3, hemoglobin (Hb) \> 13 g/dL for males and \> 12 g/dL for females.

Exclusion

  • Evidence of decompensated liver disease.
  • Pregnant or lactating female.
  • History of any other medical disease or condition that would make the subject (in the opinion of the investigator) unsuitable for the study.
  • A current drug or alcohol addiction.

Key Trial Info

Start Date :

November 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2007

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT00656006

Start Date

November 1 2005

End Date

April 1 2007

Last Update

August 2 2013

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

University of Calgary

Calgary, Alberta, Canada, T2N 4N1

2

University of Alberta

Edmonton, Alberta, Canada, T6G 2X8

3

University of British Columbia

Vancouver, British Columbia, Canada, V5Z 3P1

4

University of Manitoba

Winnipeg, Manitoba, Canada, R3E 2P4